Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCC3616 Nepetin [520-11-6] Natural inducer of autophagy and apoptosis, inhibiting glutamate overexcitation and upregulation of the Wnt/β-catenin signaling pathway
DCC3617 Neq0502 Novel AR inhibitor, being selective for the testosterone stimulated AR-dependent prostate cancer cell
DCC3618 neq135 The first potent NAD-driven small molecular inhibitor of TcGAPDH (Trypanosoma cruzi glyceraldehyde 3-phosphate dehydrogenase)
DCC3619 nequimed176 Novel non-peptidic, non-covalent cruzain inhibitor
DCC3620 Nesiritide Acetate Human B-type natriuretic peptide, facilitating cardiovascular fluid homeostasis through counterregulation of the renin-angiotensin-aldosterone system, stimulating cyclic guanosine monophosphate, leading to smooth muscle cell relaxation
DCC3621 Nestifylline Anti-inflammatory, antibronchospastic agent
DCC3622 Netarsudil Mesylate Novel dual Rho Kinase and norepinephrine transporter (ROCK/NET) inhibitor
DCC3623 Net-c343 Novel fluorescent RXR antagonist
DCC3624 N-ethylglycine Lidocaine metabolite, showing antinociceptive effects, inhibiting GlyT1-mediated glycine uptake
DCC3625 N-ethylmaleimide Modulator of the T1007 site, resulting in rapid activation of this transporter and potentiating KCC2 activity
DCC3626 Neu321 Ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth
DCC3627 Neu-4854 Novel potent Trypanosoma brucei Inhibitor
DCC3628 Neu617 Novel inhibitor of the growth of protozoan parasites, against T. brucei bloodstream proliferation
DCC3629 Neu-730 Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation
DCC3630 Neurodazole Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons
DCC3631 Neuroprotectant-7 Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB)
DCC3632 Neurotensin(8-13) The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain
DCC3633 Nexturastat A-crbn-12d Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells
DCC3634 Nfat-133 Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities
DCC3635 Nf-kappab Inhibitor-2 First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation
DCC3636 N-formyl-met-phe Neutrophil Dysfunction Test Peptide
DCC3637 Nfu1827 Novel inhibitor of human cytomegalovirus (HCMV) infection
DCC3638 Ngd 98-2 New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist
DCC3639 Ngd-8243 Novel TRPV1 Antagonist
DCC3640 Ngd9002 New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist
DCC3641 Ngp1-01 Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th
DCC3642 Nh2-bodipy Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells
DCC3643 Nh2-nplh2 Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo
DCC3644 Nh2-uamc1110 UAMC1110 Conjugate Linker
DCC3645 Nhi-1j Selective Inhibitor of Human Lactate Dehydrogenase Isoform A (LDH-A)

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>